BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 3, 2002
View Archived Issues
FDA Says Animal Studies Enough For Drugs To Counter Bioterrorism
WASHINGTON - A new FDA regulation allows drugs developed as antidotes to biological and chemical warfare to gain regulatory approval based on animal studies when human efficacy trials are not ethical. (BioWorld Today)
Read More
Vion Stock Drops On News Of Staff Cuts, Realignment
Read More
Chip Analysis, Mouse-Mimicking Disease In Multiple Sclerosis May Reveal Possible Therapeutic Ploy
Read More
Proteome Sciences Paying £12.6M For Aventis' Proteomics Division
Read More
Other News To Note
Read More